Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 1934-1938

  McVay, Catherine S ^a,b   Velásquez, Marisela ^a,c   Fralick, Joe A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b AUBURN UNIVERSITY   (United States)

^c KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BURN INFECTION; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL;

ANIMALS; BURNS; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; TREATMENT OUTCOME; WOUND INFECTION;

EID: 34250169414     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01028-06     Document Type: Article

References (35)

1. Adams, M. (ed.). 1959. Bacteriophages. Interscience Publishers, London, United Kingdom.
2. Ahmad, S. I. 2002. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Med. Hypoth. 58:327-331.
3. Barrow, P., M. A. Lovell, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:294-298.
4. Berchieri, A., M. A. Lovell, and P. A. Barrow. 1991. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142:541-549.
5. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
6. Bull, J. J., B. R. Levin, T. DeRouin, N. Walker, and C. D. Bloch. 2002. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2:35-45.
7. Capparelli, R., I. Ventimiglia, S. Roperto, D. Fenizia, and D. Iannelli. 2006. Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect. 12:248-253.
8. Church, D., S. Elsayed, O. Reid, B. Winston, and R. Lindsay. 2006. Burn wound infections. Clin. Microbiol. Rev. 19:403-434.
9. Cryz, S. J., Jr. 1984. Pseudomonas aeruginosa infections, p. 317-351. In R. Geermainier (ed.), Bacterial vaccines. Academic Press, Inc., New York, NY.
10. Danelishvili, L., L. S. Young, and L.E. Bermudez. 2006. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium. Microb. Drug Resist. 12:1-6.
11. Hamood, A. N., J. A. Griswold, and C. Duhan. 1996. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J. Surg. Res. 61:425-432.
12. Holloway, B. W., V. Krishnapillai, and A. F. Morgan. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102.
13. Inal, J. M. 2003. Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. (Warsaw) 51:237-244.
14. Loc Carrillo, C. L., R. D. J. Atterbury, A. El-Shibiny, P. L. Connerton, E. Dillon, A. Scott, and I. F. Connerton. 2005. Bacteriophage therapy to reduce Camplylobacter jejuni colonization of broiler chickens. Appl. Environ. Microbiol. 71:6554-6563.
15. MacManus, A. T., A. D. Mason, Jr., W. F. McManus, and B. A. Pruitt, Jr. 1985. Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur. J. Clin. Microbiol. 4:219-223.
16. Mann, N. H. 2005. The third age of phage. PLoS Biol. 3:e182.
17. Mathur, M. D., S. Bidhani, and P. L. Mehndiratta. 2003. Bacteriophage therapy: an alternative to conventional antibiotics. J. Assoc. Physicians India 51:593-596.
18. Matsuzaki, S., M. Rashel, J. Uchiyma, T. Ujihara, M. Kuroda, M. Ikeuchi, M. Fujieda, J. Wakiguchi, and S. Imai. 2005. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. 11:211-219.
19. Merril, C. R., B. Biswas, R. Carlon, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
20. Pruitt, B. A., Jr. 1984. The diagnosis and treatment of infection in the burn patient. Burns 11:79-91.
21. Rumbaugh, K. P., J. A. Griswold, B. H. Iglewski, and A. N. Hamood. 1999. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect. Immun. 67:5854-5862.
22. Skurnik, M., and E. Strauch. 2006. Phage therapy: facts and fiction. Int. J. Med. Microbiol. 296:5-14.
23. Slopek, S., I. Durlakowa, B. Weber-Dabrowska, A. Kucharewicz- Drukowsda, M. Dabrowski, and R. Bisikiewicz. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35:569-583.
24. Smith, H. W., and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phages: its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
25. Smith, H. W., and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhea in calves, piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
26. Smith, H. W., and M. B. Huggins. 1987. The control of experimental Escherichia coli diarrhea in calves by means of bacteriophage. J. Gen. Microbiol. 133:1111-1126.
27. Soothill, J. S. 1994. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20:209-211.
28. Stieritz, D. D., and I. A. Holder. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131:688-691.
29. Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
30. Summers, W. C. 2001. Bacteriophage therapy. Annu. Rev. Microbiol. 55:437-451.
31. Thacker, P. D. 2003. Set a microbe to kill a microbe. Drug resistance renews interest in phage therapy. JAMA 290:3183-3185.
32. Theil, K. 2004. Old dogma, new tricks - 21st century phage therapy. Nat. Biotechnol. 22:31-36.
33. Vinodkumar, C. S., Y. F. Neelagund, and S. Kalsurmath. 2005. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of mutidrug resistant Klebsiella pneumoniae. J. Communicable Dis. 37:18-29.
34. Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, D. Tao, L. Ding, E. Reed, J. Gong, A. A. Li, and J. Hu. 2006. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase producing Escherichia coli bacteremia. Int. J. Mol. Med. 17:347-355.
35. Wills, Q. F., C. Kerrigan, and J. A. Soothill. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49:1220-1221.